PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biomedica | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| +9.90p | +1.39% | 722.00p | 715.00p | 720.80p | 722.70p | 712.40p | 720.80p | 73,962 | 16:35:20 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 37.6 | -11.8 | -0.3 | - | 476.81 |
Oxford Biomedica (OXB) News Headlines
Oxford Biomedica News
| Date | Time | Source | Headline |
|---|---|---|---|
| 06/12/2018 | 17:07 | ALNC |  Oxford Biomedica Notes Positive US Regulator Feedback On AXO-Lenti-PD |
| 06/12/2018 | 16:14 | ALNCF | Alliance News Flash Headline |
| 06/12/2018 | 16:11 | RNSNON | Oxford Biomedica PLC Axovant FDA meeting feedback |
| 03/12/2018 | 15:42 | ALNC | Oxford Biomedica Notes Results Of Longer Term Kymriah Analysis |
| 03/12/2018 | 09:54 | UKREG | Oxford Biomedica PLC Total Voting Rights |
| 03/12/2018 | 07:01 | UKREG | Oxford Biomedica PLC Longer term Kymriah efficacy and safety data |
| 01/12/2018 | 19:50 | BW | Oxford BioMedica Notes the Longer-Term Analyses from Pivotal Kymriah®.. |
| 23/11/2018 | 11:08 | ALNC | Oxford BioMedica Invests GBP4 Million In Medicines Production |
| 23/11/2018 | 10:41 | UKREG | Oxford Biomedica PLC Director Dealings |
| 23/11/2018 | 07:00 | UKREG | Oxford Biomedica PLC Oxford Biomedica form digital framework initiative |
1 Year Oxford Biomedica Chart |
Intraday Oxford Biomedica Chart |
